Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) CEO Patrick W. Smith sold 53,683 shares of the company’s stock in a transaction on Monday, January 23rd. The stock was sold at an average price of $190.17, for a total value of $10,208,896.11. Following the transaction, the chief executive officer now directly owns 2,475,880 shares in the company, valued at $470,838,099.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Axon Enterprise Price Performance
NASDAQ:AXON opened at $188.96 on Wednesday. Axon Enterprise, Inc. has a one year low of $82.49 and a one year high of $194.80. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.39 and a current ratio of 2.79. The firm has a market cap of $13.45 billion, a price-to-earnings ratio of 130.32 and a beta of 0.79. The firm’s fifty day moving average is $177.62 and its two-hundred day moving average is $146.37.
Axon Enterprise (NASDAQ:AXON – Get Rating) last posted its quarterly earnings results on Tuesday, November 8th. The biotechnology company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.06 by $0.24. Axon Enterprise had a net margin of 9.75% and a return on equity of 9.88%. The company had revenue of $311.75 million for the quarter, compared to analyst estimates of $276.99 million. Research analysts expect that Axon Enterprise, Inc. will post 0.54 EPS for the current year.
Institutional Investors Weigh In On Axon Enterprise
Analysts Set New Price Targets
AXON has been the topic of several research reports. Morgan Stanley upped their target price on Axon Enterprise from $130.00 to $155.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 13th. Credit Suisse Group upped their target price on Axon Enterprise from $152.00 to $200.00 and gave the company an “outperform” rating in a research report on Tuesday, January 10th. Needham & Company LLC upped their target price on Axon Enterprise from $130.00 to $200.00 and gave the company a “buy” rating in a research report on Wednesday, November 9th. Robert W. Baird upped their target price on Axon Enterprise from $170.00 to $200.00 in a research report on Thursday, December 15th. Finally, StockNews.com initiated coverage on Axon Enterprise in a research report on Wednesday, October 12th. They issued a “hold” rating on the stock. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $181.13.
About Axon Enterprise
Axon Enterprise, Inc engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services.
- Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.